The latest immunotherapy news and developments
Tasmanian devil research could help tackle immunotherapy resistance
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil…
Browsing: Immunotherapy
ANZUP Trial’s TheraP and UNISoN reach recruitment
By Nicole Tankard, ANZUP ANZUP, the Australian and New Zealand Urogenital and Prostate cancer trials…
Electronic nose can sniff out which lung cancer patients will respond to immunotherapy
An electronic nose that detects chemicals in the breath of lung cancer patients can identify…
A liquid biopsy test can identify patients who may respond to immune checkpoint blockade
A new liquid biopsy test could detect microsatellite instability (MSI) and tumour mutational burden (TMB),…
B cells linked to immunotherapy for melanoma
Researchers at EMBL’s European Bioinformatics Institute and the Medical University of Vienna have found evidence…
Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer
Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to…
Delivering immunotherapy directly to brain tumours
A new study gives insight into how immunotherapies, treatments that help the body’s immune system…
Researchers make immunotherapy work for treatment-resistant lymphoma
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin’s lymphomas…
Why are some cancers unresponsive to checkpoint inhibitors?
New research has uncovered a mechanism thought to explain why some cancers don’t respond to…
Scientists develop novel nano-vaccine for melanoma
Researchers have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.…